Press Release Feb 17, 2026 Lumanity Becomes First Life Sciences Value Demonstration Partner to Achieve ISO 42001 Certification, Setting a New Standard for Responsible AI in Life Sciences
Press Release Feb 17, 2026 Lumanity Becomes First Life Sciences Value Demonstration Partner to Achieve ISO 42001 Certification, Setting a New Standard for Responsible AI in Life Sciences
View Feb 27, 2026 Rare Disease Day 2026: Moving Forward with FDA Innovation and Patient-Centered Progress Take a look
Case Study Feb 4, 2026 AVEO Oncology and Lumanity Leverage PulsePoint’s NPI-Level Insights and Media Capabilities
View Feb 4, 2026 From Reflection to Action: Making Patient Experience Data a True Driver of Change in EU Medicines Regulation
View Jan 21, 2026 GP Consultations for Venous Thromboembolism (VTE) After mRNA and Adeno-Vector-Based COVID-19 Vaccination—An Exposure-Anchored Self-Controlled Cohort Study Based on Primary Healthcare Data From the Netherlands
